Analyst ratings jnj
JNJ Price Target Summary. Highest: $163.00 (Goldman Sachs) Lowest: $140.00 (Barclays) Average: $150.47 Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. Popular Channels Analyst Ratings View today's stock price, news and analysis for Johnson & Johnson (JNJ). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Buy Johnson & Johnson (JNJ) on Baby Powder Weakness - Bernstein Johnson & Johnson (JNJ) Ticks Off Lows on Analyst Defense Atlantic Equities Upgrades Johnson & Johnson (JNJ) to Neutral See Johnson & Johnson (JNJ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View today's stock price, news and analysis for Johnson & Johnson (JNJ). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Analyst ratings. JNJ stock has risen 27.9% in the last 12 months. Analysts estimate that the stock could rise 1.4% over the next 12 months. Analyst recommendations show a 12-month target price of
We apologize for any inconvenience. Refresh or try again later. PRESS RELEASES · Johnson & Johnson
Buy Johnson & Johnson (JNJ) on Baby Powder Weakness - Bernstein Johnson & Johnson (JNJ) Ticks Off Lows on Analyst Defense Atlantic Equities Upgrades Johnson & Johnson (JNJ) to Neutral See Johnson & Johnson (JNJ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View today's stock price, news and analysis for Johnson & Johnson (JNJ). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Analyst ratings. JNJ stock has risen 27.9% in the last 12 months. Analysts estimate that the stock could rise 1.4% over the next 12 months. Analyst recommendations show a 12-month target price of Merrill Lynch analyst Bob Hopkins maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) today and set a price target of $150. The company’s shares closed yesterday at $134.71. According to TipRanks.com, Hopkins is a 4-star analyst Johnson & Johnson (JNJ) Receives a Buy from Goldman Sachs. 27 August, 2019. In a report released today, Terence Flynn from Goldman Sachs maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price target of $169. The company's shares closed last Monday at $129.64.
Based on analysts offering 12 month price targets for JNJ in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. Popular Channels Analyst Ratings View today's stock price, news and analysis for Johnson & Johnson (JNJ). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Buy Johnson & Johnson (JNJ) on Baby Powder Weakness - Bernstein Johnson & Johnson (JNJ) Ticks Off Lows on Analyst Defense Atlantic Equities Upgrades Johnson & Johnson (JNJ) to Neutral See Johnson & Johnson (JNJ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View today's stock price, news and analysis for Johnson & Johnson (JNJ). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.
Their average twelve-month price target is $152.10, suggesting that the stock has a possible upside of 19.11%. The high price target for JNJ is $169.00 and the low price target for JNJ is $140.00. There are currently 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy.".
13 Wall Street analysts have issued ratings and price targets for Johnson & Johnson in the last 12 months. Their average twelve-month price target is $162.73, Based on 7 analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is $165.86 with a high forecast of Find the latest analyst research for Johnson & Johnson Common Stock (JNJ) at Nasdaq.com. Analyst Firms Making Recommendations Johnson & Johnson analyst ratings, historical stock prices, earnings estimates & actuals. JNJ updated stock price target summary. The 17 analysts offering 12-month price forecasts for Johnson & Johnson This rating has held steady since March, when it was unchanged from a Buy rating.
JNJ: Johnson & Johnson broker recommendations. Get the latest broker recommendations from Zacks Investment Research. for JNJ · Analyst | Snapshot
JNJ updated stock price target summary. Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Based on analysts offering 12 month price targets for JNJ in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . See Johnson & Johnson (JNJ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Their average twelve-month price target is $152.10, suggesting that the stock has a possible upside of 19.11%. The high price target for JNJ is $169.00 and the low price target for JNJ is $140.00. There are currently 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy.". Analyst Ratings for Johnson & Johnson (JNJ) provide recommendations made by outside industry experts. Analyst Ratings for Johnson & Johnson (JNJ) provide recommendations made by outside industry experts. Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here. Number of Ratings: 19 Current Quarters Estimate: 2.14: FY Report Date: 12 / 2020 Current Year's Estimate: 8.98: Last Quarter's Earnings: 1.88: Median PE on CY Estimate: N/A
The 17 analysts offering 12-month price forecasts for Johnson & Johnson This rating has held steady since March, when it was unchanged from a Buy rating. Johnson & Johnson. JNJ Number of Analysts, 20 HOLD UNDERPERFORM SELL Without OPINION ©marketscreener.com - S&P Global Market Intelligence.